LoTox™ SARS-CoV-2 Nucleocapsid RNA-Binding Domain (LTR-CV2-NCR-4)

Product Code:

LTR-CV2-NCR-4

Protein:

SARS-CoV-2 Nucleocapsid, RNA binding domain (aa 46- aa 173)

Volume:

1mg

Source:

E. coli

Mol. Wt:

15 kD

Purification:

Purified from E. coli by multi-step chromatography.

Purity:

Purity >95% by silver stain SDS-PAGE and InBio^®MS (LC-MS/MS, relative abundance).

Validation:

Validated by IgG antibody ELISA using serum samples (n=10) from COVID-19 patients.

Concentration:

xx based on OD 280nm. Extinction Coefficient = 1.8.

Formulation:

Preservative and carrier-free in 0.3M NaCl, 1X PBS, pH 7.4.

Filtered through 0.22µm filter.

Storage:

Store at -20ºC. Avoid repeated freeze-thaw cycles.

Notes:

Product Resources:

(1) SARS-CoV-2 NCR has a C-terminal 7xHis-tag.

(2) Point mutation (P46G) introduced to increase stability.

(3) A LoTox™ product, Endotoxin < 0.03 EU/µg.

For research and commercial use in vitro: not for human in vivo or therapeutic use.

An InBio® product. Made in the USA

No files to download

Qty

$3,095.00